First Manhattan’s 10x Genomics TXG Stock Holding History

First Manhattan’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11	Closed	-$412	–	1275
2024 Q1	$412	Hold	11	–	–	﹤0.01%	1356
2023 Q4	$615	Hold	11	–	–	﹤0.01%	1353
2023 Q3	$453	Hold	11	–	–	﹤0.01%	1380
2023 Q2	$614	Hold	11	–	–	﹤0.01%	1360
2023 Q1	$613	Hold	11	–	–	﹤0.01%	1454
2022 Q4	$400	Hold	11	–	–	﹤0.01%	1618
2022 Q3	$0	Hold	11	–	–	﹤0.01%	1653
2022 Q2	$0	Hold	11	–	–	﹤0.01%	1673
2022 Q1	$0	Hold	11	–	–	﹤0.01%	1690
2021 Q4	$1K	Hold	11	–	–	﹤0.01%	1545
2021 Q3	$1K	Buy	+11	New	+$1.89K	﹤0.01%	1566

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

First Manhattan's TXG Position: Q2 2024 in Review

First Manhattan sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 11 shares — an estimated $412 sold.

First Manhattan first reported a position in TXG in Q3 2021 and held it in 11 quarters. The position peaked at $1K in Q4 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

First Manhattan reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 11 10x Genomics shares in Q2 2024, an estimated $412.
First Manhattan first reported a position in 10x Genomics in Q3 2021 and held it in 11 quarters.
First Manhattan's 10x Genomics position peaked at $1K in Q4 2021.
261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.